![BX - Blackstone Inc - Stock Price Chart]() |
Market Cap | 204.70B | EPS (ttm) | 3.31 |
P/E | 51.04 | EPS this Y | 4.23% |
Forward P/E | 26.41 | EPS next Y | 32.11% |
PEG | 2.58 | EPS past 5Y | 3.62% |
P/S | 16.21 | EPS next 5Y | 19.78% |
P/B | 25.83 | EPS Q/Q | -28.58% |
Dividend | 2.49% | Sales Q/Q | 6.26% |
Insider Own | 40.50% | Inst Own | 42.60% |
Insider Trans | -0.40% | Inst Trans | 0.25% |
Short Float | 1.76% | Earnings | Jul 24/b |
Analyst Recom | 2.32 | Target Price | 158.63 |
Avg Volume | 3.87M | 52W Range | 115.66 - 200.28 |
|
|
|
Blackstone, Inc. engages in the provision of investment and fund management services. It operates through the following segments: Real Estate, Private Equity, Credit and Insurance, and Hedge Fund Solutions. The Real Estate segment includes management of opportunistic real estate funds, Core+ real estate funds, high-yield real estate debt funds, and liquid real estate debt funds. The Private Equity segment consists of management of flagship corporate private equity funds, sector and geographically focused corporate private equity funds, core private equity funds, an opportunistic investment platform, a secondary fund of funds business, infrastructure-focused funds, a life sciences investment platform, a growth equity investment platform, a multi-asset investment program for eligible high net worth investors and a capital markets services business. The Credit and Insurance segment refers to Blackstone Credit, which is organized into two overarching strategies: private credit which includes mezzanine direct lending funds, private placement strategies, stressed and distressed strategies and energy strategies, and liquid credit which consists of CLOs, closed-ended funds, open ended funds and separately managed accounts. In addition, the segment includes an insurer-focused platform, an asset-based finance platform, and publicly traded master limited partnership investment platform. The Hedge Fund Solutions segment focuses on Blackstone Alternative Asset Management, which manages a broad range of commingled and customized hedge fund of fund solutions. It also includes a GP Stakes business and investment platforms that invest directly, as well as investment platforms that seed new hedge fund businesses and create alternative solutions through daily liquidity products. The company was founded by Stephen Allen Schwarzman in 1985 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Blackstone Holdings I L.P. | 10% Owner | Jul 18 '25 | Buy | 25.22 | 1,189,532 | 30,000,000 | 4,178,771 | Jul 18 05:42 PM | Blackstone Charitable Foundati | Affiliate | Jun 23 '25 | Proposed Sale | 137.69 | 142,857 | 19,669,980 | | Jun 23 04:44 PM | Blackstone Holdings IV L.P. | 10% Owner | Jun 09 '25 | Sale | 82.61 | 3,000,000 | 247,830,000 | 125,840 | Jun 11 04:30 PM | Blackstone Holdings IV L.P. | 10% Owner | May 16 '25 | Sale | 80.91 | 1,557,994 | 126,053,711 | 178,816 | May 20 04:33 PM | Blackstone Holdings IV L.P. | 10% Owner | May 19 '25 | Sale | 80.91 | 234,563 | 18,977,953 | 174,974 | May 20 04:33 PM |
|
|
 |
![CBAN - Colony Bankcorp, Inc - Stock Price Chart]() |
Market Cap | 305.61M | EPS (ttm) | 1.43 |
P/E | 12.22 | EPS this Y | 11.99% |
Forward P/E | 9.39 | EPS next Y | 14.07% |
PEG | - | EPS past 5Y | 3.98% |
P/S | 1.71 | EPS next 5Y | - |
P/B | 1.07 | EPS Q/Q | 24.37% |
Dividend | 2.63% | Sales Q/Q | 4.14% |
Insider Own | 11.07% | Inst Own | 52.34% |
Insider Trans | 0.51% | Inst Trans | 0.85% |
Short Float | 0.91% | Earnings | Jul 23/a |
Analyst Recom | 2.00 | Target Price | 19.25 |
Avg Volume | 56.57K | 52W Range | 13.00 - 18.49 |
|
|
|
Colony Bankcorp, Inc. is a bank holding company, which engages in the stockholder and investor relations functions through its subsidiary, Colony Bank. It operates through the following segments: Banking Division, Mortgage Division, and Small Business Specialty Lending Division. The Banking Division segment offers full service financial services including commercial loans, consumer loans and deposit accounts. The Mortgage Division segment consists of sales and servicing of one-to-four family residential mortgage loans. The Small Business Specialty Lending Division segment focuses on the selling and servicing of SBA and USDA government guaranteed loans. The company was founded on November 8, 1982 and is headquartered in Fitzgerald, GA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Canup Edward G | CHIEF BANKING OFFICER | Mar 13 '25 | Buy | 16.28 | 3,146 | 51,215 | 6,766 | Jul 18 04:24 PM | Joiner Paul E III | Director | May 30 '25 | Buy | 15.01 | 6,150 | 92,312 | 6,150 | Jun 02 04:44 PM | Canup Edward G | CHIEF BANKING OFFICER | Mar 11 '25 | Buy | 15.65 | 500 | 7,825 | 16,884 | Mar 14 04:38 PM |
|
|
 |
![STSS - Sharps Technology Inc - Stock Price Chart]() |
Market Cap | 5.94M | EPS (ttm) | -1647.57 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -8.46% |
P/S | - | EPS next 5Y | - |
P/B | 0.28 | EPS Q/Q | 111.11% |
Dividend | - | Sales Q/Q | - |
Insider Own | 0.32% | Inst Own | 5.88% |
Insider Trans | - | Inst Trans | 0.05% |
Short Float | 12.93% | Earnings | May 15/b |
Analyst Recom | 1.00 | Target Price | 105600.00 |
Avg Volume | 1.30M | 52W Range | 3.36 - 2224.20 |
|
|
|
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. It also focuses on low waste, and ultra-low waste syringe technologies that incorporate both passive and active safety features. The company was founded by Alan R. Blackman and Barry B. Berler on December 16, 2017 and is headquartered in Melville, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
DANNER PAUL K | Director | Jul 15 '25 | Buy | 20.00 | 5 | 100 | 5 | Jul 18 02:48 PM | Hayes Robert Michael | Chief Executive Officer | Feb 28 '25 | Buy | 0.04 | 175,000 | 7,000 | 275,882 | Apr 01 05:24 PM | Hayes Robert Michael | Chief Executive Officer | Mar 31 '25 | Buy | 0.03 | 125,000 | 3,750 | 400,882 | Apr 01 05:24 PM | Hayes Robert Michael | Chief Executive Officer | Dec 04 '24 | Buy | 1.99 | 3,300 | 6,565 | 99,182 | Dec 05 06:12 PM | Hayes Robert Michael | Chief Executive Officer | Dec 05 '24 | Buy | 2.06 | 1,700 | 3,507 | 100,882 | Dec 05 06:12 PM |
|
|
|  |
![RMMZ - RiverNorth Managed Duration Municipal Income Fund II Inc - Stock Price Chart]() |
Market Cap | 117.95M | EPS (ttm) | 0.79 |
P/E | 17.66 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | 7.56% | Sales Q/Q | - |
Insider Own | 8.80% | Inst Own | 13.08% |
Insider Trans | 0.68% | Inst Trans | - |
Short Float | 0.13% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 32.08K | 52W Range | 13.79 - 16.56 |
|
|
|
 |
![CALC - CalciMedica Inc - Stock Price Chart]() |
Market Cap | 42.06M | EPS (ttm) | -1.55 |
P/E | - | EPS this Y | -26.02% |
Forward P/E | - | EPS next Y | 1.63% |
PEG | - | EPS past 5Y | 47.54% |
P/S | - | EPS next 5Y | -13.56% |
P/B | 3.86 | EPS Q/Q | -2867.44% |
Dividend | - | Sales Q/Q | - |
Insider Own | 54.45% | Inst Own | 22.31% |
Insider Trans | 0.58% | Inst Trans | 105.11% |
Short Float | 1.68% | Earnings | May 14/b |
Analyst Recom | 1.00 | Target Price | 16.00 |
Avg Volume | 42.25K | 52W Range | 1.42 - 5.97 |
|
|
|
CalciMedica, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. The firm's product candidate, Auxora, helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
WILSON ROBERT N | Director | Jul 18 '25 | Buy | 2.87 | 4,500 | 12,915 | 422,029 | Jul 18 02:42 PM | Roberts Eric W | CHIEF BUSINESS OFFICER | Jul 18 '25 | Buy | 2.88 | 2,000 | 5,760 | 46,323 | Jul 18 02:36 PM | Roberts Eric W | CHIEF BUSINESS OFFICER | Jul 14 '25 | Buy | 2.43 | 6,500 | 15,810 | 44,323 | Jul 16 12:58 PM | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | Jul 14 '25 | Buy | 2.47 | 2,500 | 6,175 | 2,500 | Jul 15 09:29 PM | Roberts Eric W | CHIEF BUSINESS OFFICER | Jul 09 '25 | Buy | 1.60 | 5,000 | 8,024 | 37,823 | Jul 10 08:18 PM |
|
|
|  |
![ELV - Elevance Health Inc - Stock Price Chart]() |
Market Cap | 62.60B | EPS (ttm) | 23.49 |
P/E | 11.79 | EPS this Y | -2.40% |
Forward P/E | 7.88 | EPS next Y | 9.06% |
PEG | 2.02 | EPS past 5Y | 6.81% |
P/S | 0.33 | EPS next 5Y | 5.85% |
P/B | 1.42 | EPS Q/Q | -21.67% |
Dividend | 2.44% | Sales Q/Q | 14.04% |
Insider Own | 0.17% | Inst Own | 92.82% |
Insider Trans | -0.01% | Inst Trans | -1.47% |
Short Float | 1.13% | Earnings | Jul 17/b |
Analyst Recom | 1.71 | Target Price | 413.17 |
Avg Volume | 1.87M | 52W Range | 296.39 - 567.26 |
|
|
Today | Downgrade |
Leerink Partners |
Outperform → Market Perform |
$310 |
|
|
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
BOUDREAUX GAIL | President and CEO | Jul 18 '25 | Buy | 286.94 | 8,500 | 2,438,951 | 151,020 | Jul 18 01:42 PM | Kaye Mark | EVP & CFO | Apr 24 '25 | Sale | 424.82 | 4,588 | 1,949,074 | 18,977 | Apr 25 04:17 PM | Kaye Mark | Officer | Apr 24 '25 | Proposed Sale | 424.81 | 4,588 | 1,949,051 | | Apr 24 05:10 PM | Penczek Ronald W | CAO & Controller | Mar 10 '25 | Sale | 415.13 | 443 | 183,903 | 1,847 | Mar 11 04:20 PM | Penczek Ronald W | Officer | Mar 10 '25 | Proposed Sale | 415.13 | 443 | 183,904 | | Mar 10 02:55 PM |
|
|
 |
![NEGG - Newegg Commerce Inc - Stock Price Chart]() |
Market Cap | 573.16M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 43.78% |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | -364.23% |
Dividend | - | Sales Q/Q | -27.42% |
Insider Own | 98.89% | Inst Own | 0.44% |
Insider Trans | 3.66% | Inst Trans | 16.78% |
Short Float | 271.84% | Earnings | Apr 28/b |
Analyst Recom | 1.00 | Target Price | 60.00 |
Avg Volume | 738.67K | 52W Range | 3.32 - 56.00 |
|
|
|
Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Galkin Vladimir | 10% Owner | Jul 17 '25 | Buy | 29.41 | 111,111 | 3,267,998 | 2,777,777 | Jul 18 01:14 PM | Galkin Vladimir | 10% Owner | Jul 16 '25 | Buy | 28.17 | 111,111 | 3,129,774 | 26,622,221 | Jul 18 01:14 PM | Galkin Vladimir | 10% Owner | Jul 15 '25 | Buy | 29.56 | 111,111 | 3,284,700 | 2,555,555 | Jul 16 12:51 PM | Galkin Vladimir | 10% Owner | Jul 14 '25 | Buy | 41.14 | 222,222 | 9,141,745 | 2,444,444 | Jul 15 12:15 PM | Galkin Vladimir | 10% Owner | Jul 09 '25 | Buy | 21.77 | 57,920 | 1,260,918 | 2,222,222 | Jul 14 07:14 PM |
|
|
|  |
![RCG - RENN Fund Inc - Stock Price Chart]() |
Market Cap | 18.24M | EPS (ttm) | 0.79 |
P/E | 3.29 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 49.11 | EPS next 5Y | - |
P/B | 0.95 | EPS Q/Q | - |
Dividend | 0.85% | Sales Q/Q | 41.50% |
Insider Own | 16.17% | Inst Own | 16.94% |
Insider Trans | 15.76% | Inst Trans | - |
Short Float | 0.07% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 7.96K | 52W Range | 1.65 - 2.88 |
|
|
|
RENN Fund, Inc. is a closed ended equity mutual fund launched by RENN Capital Group, Inc. The fund is co-managed by Horizon Kinetics Asset Management LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It seeks to invest in stocks of small-cap and mid-cap companies. The fund employs a fundamental analysis with a bottom-up stock picking approach to create its portfolio. It was formerly known as RENN Global Entrepreneurs Fund, Inc. RENN Fund, Inc. was formed on January 20, 1994 and is domiciled in the United States. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
STAHL MURRAY | President/Co-Portfolio Manager | Jul 17 '25 | Buy | 2.65 | 774 | 2,051 | 314,294 | Jul 18 11:44 AM | STAHL MURRAY | President/Co-Portfolio Manager | Jul 17 '25 | Buy | 2.65 | 356 | 943 | 95,698 | Jul 18 11:44 AM | STAHL MURRAY | President/Co-Portfolio Manager | Jul 16 '25 | Buy | 2.65 | 774 | 2,051 | 313,998 | Jul 17 12:38 PM | STAHL MURRAY | President/Co-Portfolio Manager | Jul 16 '25 | Buy | 2.65 | 356 | 943 | 95,342 | Jul 17 12:38 PM | STAHL MURRAY | President/Co-Portfolio Manager | Jul 15 '25 | Buy | 2.65 | 774 | 2,051 | 313,702 | Jul 16 10:38 AM |
|
|
 |
![TPL - Texas Pacific Land Corporation - Stock Price Chart]() |
Market Cap | 22.92B | EPS (ttm) | 19.99 |
P/E | 49.88 | EPS this Y | 12.10% |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 7.60% |
P/S | 31.50 | EPS next 5Y | - |
P/B | 19.00 | EPS Q/Q | 5.40% |
Dividend | 0.60% | Sales Q/Q | 12.60% |
Insider Own | 0.20% | Inst Own | 70.80% |
Insider Trans | -2.08% | Inst Trans | 0.06% |
Short Float | 6.84% | Earnings | Aug 06/a |
Analyst Recom | - | Target Price | 1100.96 |
Avg Volume | 132.21K | 52W Range | 736.75 - 1769.14 |
|
|
|
Texas Pacific Land Corporation engages in the land and resource management, and water services and operations businesses. The Land and Resource Management segment manages surface acres of land, and oil and gas royalty interest in Permian Basin. This segment also engages in easements, such as transporting oil, gas and related hydrocarbons, power line and utility, and subsurface wellbore easements. In addition, this segment leases its land for processing, storage, and compression facilities and roads; and is involved in sale of materials, such as caliche, sand, and other material, as well as sells land. The Water Services and Operations segment provides full-service water offerings, including water sourcing, produced-water treatment, infrastructure development, and disposal solutions to operators in the Permian Basin. This segment also holds produced water royalties. The company owns a 1/128th nonparticipating perpetual oil and gas royalty interest (NPRI) under approximately 85,000 acres of land; a 1/16th NPRI under approximately 371,000 acres of land; and approximately 16,000 additional net royalty acres, total of approximately 207,000 NRA located in the Permian Basin. Texas Pacific Land Corporation was founded in 1888 and is headquartered in Dallas, Texas. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
HORIZON KINETICS ASSET MANAGEM | 10% Owner | Jul 17 '25 | Buy | 992.87 | 1 | 993 | 1,163,955 | Jul 18 11:22 AM | HORIZON KINETICS ASSET MANAGEM | 10% Owner | Jul 16 '25 | Buy | 961.67 | 1 | 962 | 1,163,954 | Jul 17 02:28 PM | HORIZON KINETICS ASSET MANAGEM | 10% Owner | Jul 15 '25 | Buy | 1014.80 | 1 | 1,015 | 1,163,953 | Jul 16 11:31 AM | HORIZON KINETICS ASSET MANAGEM | 10% Owner | Jul 14 '25 | Buy | 1033.53 | 1 | 1,034 | 1,163,952 | Jul 15 01:41 PM | HORIZON KINETICS ASSET MANAGEM | 10% Owner | Jul 11 '25 | Buy | 1062.60 | 1 | 1,063 | 1,163,951 | Jul 14 11:15 AM |
|
|
 |
![GALT - Galectin Therapeutics Inc - Stock Price Chart]() |
Market Cap | 177.21M | EPS (ttm) | -0.72 |
P/E | - | EPS this Y | 11.84% |
Forward P/E | - | EPS next Y | 2.99% |
PEG | - | EPS past 5Y | -23.89% |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | 18.06% |
Dividend | - | Sales Q/Q | - |
Insider Own | 31.40% | Inst Own | 15.74% |
Insider Trans | 0.03% | Inst Trans | 0.28% |
Short Float | 17.94% | Earnings | May 15/b |
Analyst Recom | 1.00 | Target Price | 6.00 |
Avg Volume | 604.02K | 52W Range | 0.73 - 3.90 |
|
|
|
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
FREEMAN KEVIN D | Director | Jul 17 '25 | Buy | 2.90 | 5,000 | 14,495 | 49,769 | Jul 18 10:38 AM | CZIRR JAMES C | 10% Owner | Jun 06 '25 | Option Exercise | 2.16 | 323,125 | 699,344 | 1,045,541 | Jun 11 06:25 PM | Shlevin Harold H. | Director | Dec 30 '24 | Buy | 1.16 | 6,500 | 7,540 | 15,206 | Dec 31 07:45 AM | Jamil Khurram | Chief Medical Officer | Dec 23 '24 | Option Exercise | 0.00 | 40,000 | 0 | 40,000 | Dec 26 08:20 AM | Jamil Khurram | Chief Medical Officer | Dec 23 '24 | Sale | 0.88 | 13,654 | 12,044 | 26,346 | Dec 26 08:20 AM |
|
|
|